Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.411NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.411NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.411NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.217NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.217NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.217NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.35NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.35NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.17 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.17 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.17 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.41NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.41NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.41NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.527NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.527NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.527NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.18NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.18NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.500NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-19690.7US
B.1.1.500NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.500NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.147NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.147NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.147NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.487NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.487NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.487NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.68NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
B.1.177.68NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.68NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
B.1.1.121NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.121NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.121NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AA.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AA.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AA.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AS.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AS.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AS.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.115NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.115NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.115NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.127.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.127.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.127.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.88NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.88NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used